Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Solabegron hydrochloride induces bladder relaxation and improves bladder storage mechanism in vivo

May 24, 2005

GSK discloses novel agents for renal and cardiovascular disorders and cancer

May 9, 2005

A new 5-HT4 receptor antagonist shows promise in the treatment of urinary incontinence

May 6, 2005

DA-8159 as a treatment for diabetic erectile dysfunction

May 2, 2005

Good cardiovascular profile reported for avanafil in male volunteers

April 28, 2005

Novel agents for urinary incontinence and renal disorders imparted in recent patents

April 27, 2005

Theravance presents novel agents for overactive bladder

April 22, 2005

Fast track designation for terlipressin in type 1 hepatorenal syndrome

April 22, 2005

Greater efficacy found with a duloxetine/PFMT combination in women with SUI

April 22, 2005

Kentera begins European roll-out

April 20, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...